Literature DB >> 7551606

Tardive dyskinesia in schizophrenia. Relationship to minor physical anomalies, frontal lobe dysfunction and cerebral structure on magnetic resonance imaging.

J L Waddington1, E O'Callaghan, P Buckley, C Madigan, O Redmond, J P Stack, A Kinsella, C Larkin, J T Ennis.   

Abstract

BACKGROUND: It was hypothesised that schizophrenic patients with tardive dyskinesia show an excess of neurodevelopmental disturbance, particularly minor physical anomalies, in association with cognitive dysfunction and abnormalities of cerebral structure.
METHOD: Forty-seven out-patients with a DSM-III diagnosis of schizophrenia were examined for tardive dyskinesia using the Abnormal Involuntary Movement Scale; they were examined also for minor physical anomalies and neuropsychological test performance. Cortical atrophy, signal hyperintensities and lateral ventricular volume were determined on magnetic resonance imaging.
RESULTS: Patients with and without tardive dyskinesia could not be distinguished by age, gender distribution or a number of clinical measures; however, patients with tardive dyskinesia sorted fewer categories on the Wisconsin Card Sorting Test (P = 0.04). Cerebral structure in patients with and without tardive dyskinesia could not be distinguished on magnetic resonance imaging but those with dyskinesia, all of whom showed involvement of the orofacial region, showed more evident minor physical anomalies of the head relative to those of the periphery (P = 0.02).
CONCLUSIONS: Tardive orofacial dyskinesia in schizophrenia appears to be associated particularly with poorer frontal lobe function, while predominance of craniofacial dysmorphogenesis may constitute a vulnerability factor that is related to the early origins of the disease process.

Entities:  

Mesh:

Year:  1995        PMID: 7551606     DOI: 10.1192/bjp.167.1.41

Source DB:  PubMed          Journal:  Br J Psychiatry        ISSN: 0007-1250            Impact factor:   9.319


  8 in total

1.  Patterns of dysmorphic features in schizophrenia.

Authors:  L E Scutt; E W Chow; R Weksberg; W G Honer; A S Bassett
Journal:  Am J Med Genet       Date:  2001-12-08

2.  A Neural Signature of Parkinsonism in Patients With Schizophrenia Spectrum Disorders: A Multimodal MRI Study Using Parallel ICA.

Authors:  Robert C Wolf; Mahmoud Rashidi; Stefan Fritze; Katharina M Kubera; Georg Northoff; Fabio Sambataro; Vince D Calhoun; Lena S Geiger; Heike Tost; Dusan Hirjak
Journal:  Schizophr Bull       Date:  2020-07-08       Impact factor: 9.306

Review 3.  [Genuine motor phenomena in schizophrenia : Neuronal correlates and pathomechanisms].

Authors:  D Hirjak; G Northoff; P A Thomann; K M Kubera; R C Wolf
Journal:  Nervenarzt       Date:  2018-01       Impact factor: 1.214

4.  A neurobehavioral systems analysis of adult rats exposed to methylazoxymethanol acetate on E17: implications for the neuropathology of schizophrenia.

Authors:  Holly Moore; J David Jentsch; Mehdi Ghajarnia; Mark A Geyer; Anthony A Grace
Journal:  Biol Psychiatry       Date:  2006-04-11       Impact factor: 13.382

5.  Minor physical anomalies in schizophrenia: a meta-analysis.

Authors:  Seth M Weinberg; Elizabeth A Jenkins; Mary L Marazita; Brion S Maher
Journal:  Schizophr Res       Date:  2006-10-31       Impact factor: 4.939

6.  Association of tardive dyskinesia with variation in CYP2D6: Is there a role for active metabolites?

Authors:  Maju M Koola; Evangelia M Tsapakis; Padraig Wright; Shubulade Smith; Robert W Kerwin Rip; Katie L Nugent; Katherine J Aitchison
Journal:  J Psychopharmacol       Date:  2014-03-04       Impact factor: 4.153

7.  Prevalence of spontaneous dyskinesia in first episode, drug naive schizophrenia, and its relation to the positive and negative symptoms of schizophrenia.

Authors:  Samrat Singh Bhandari; Dipesh Bhagabati
Journal:  Open J Psychiatry Allied Sci       Date:  2016-12-30

8.  Gray matter abnormalities in schizophrenia patients with tardive dyskinesia: a magnetic resonance imaging voxel-based morphometry study.

Authors:  Cheng-Ta Li; Kun-Hsien Chou; Tung-Ping Su; Chu-Chung Huang; Mu-Hong Chen; Ya-Mei Bai; Ching-Po Lin
Journal:  PLoS One       Date:  2013-08-15       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.